Zipsor Capsule, Liquid Filled
NDC Package 82497-008-12

11-digit billing NDC: 82497000812
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Zipsor (diclofenac potassium) capsules is zIPSOR is indicated for relief of mild to moderate acute pain in adult and pediatric patients 12 years of age and older. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Assertio Specialty Pharmaceuticals Llc, this product is identified by NDC 82497-008 and is authorized under FDA application NDA022202.

Identification & Billing

NDC Package Code
82497-008-12
Package Description
120 CAPSULE, LIQUID FILLED in 1 BOTTLE
Product Code
82497-008
11-Digit Billing Format
82497000812
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Zipsor
Non-Proprietary Name
Diclofenac Potassium
Substance Name
Diclofenac Potassium
Dosage Form
Capsule, Liquid Filled - A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
DICLOFENAC POTASSIUM 25 mg/1
Pharmacologic Class
Usage Information
ZIPSOR is indicated for relief of mild to moderate acute pain in adult and pediatric patients 12 years of age and older.

Regulatory & Marketing

Labeler Name
Assertio Specialty Pharmaceuticals Llc
Product Type
Human Prescription Drug
FDA Application #
NDA022202
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-24-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82497-008-12 identifies a specific commercial package of 120 capsule, liquid filled in 1 bottle of Zipsor, a human prescription drug labeled by Assertio Specialty Pharmaceuticals Llc. This capsule, liquid filled is formulated for oral use and contains diclofenac potassium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Assertio Specialty Pharmaceuticals Llc on August 24, 2026. The current certification is valid through December 31, 2027.

How is this Assertio Specialty Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82497000812. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82497-008-12
11-Digit CMS (5-4-2)
82497-0008-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.